AAAAAA
Results: 1-25/50
Authors:
Peddi, VR
First, MR
Citation: Vr. Peddi et Mr. First, Recent advances in immunosuppressive therapy for renal transplantation, SEMIN DIAL, 14(3), 2001, pp. 218-222
Authors:
Chaudhury, PR
Alexander, JW
First, MR
Peddi, VR
Munda, R
Cavallo, T
Citation: Pr. Chaudhury et al., Immediate allograft dysfunction due to atheroembolic disease, AM J KIDNEY, 37(2), 2001, pp. 423-426
Authors:
Kelly, BS
Alexander, JW
Dreyer, D
Greenberg, NA
Erickson, A
Whiting, JF
Ogle, CK
Babcock, GF
First, MR
Citation: Bs. Kelly et al., Oral arginine improves blood pressure in renal transplant and hemodialysispatients, J PARENT EN, 25(4), 2001, pp. 194-202
Authors:
First, MR
Citation: Mr. First, Tailoring immunosuppressive therapy based on donor and recipient risk factors, TRANSPLAN P, 33(3), 2001, pp. 2207-2211
Authors:
First, MR
Citation: Mr. First, The organ shortage and allocation issues, TRANSPLAN P, 33(1-2), 2001, pp. 806-810
Authors:
Phillips, AL
Walker, EL
Martin, JE
First, MR
Hanto, DW
Whiting, JF
Citation: Al. Phillips et al., Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant, TRANSPLAN P, 33(1-2), 2001, pp. 1886-1886
Authors:
Boyd, SR
Martin, JE
First, MR
Whiting, JF
Citation: Sr. Boyd et al., Health utility scores following renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1900-1900
Authors:
Martin, JE
Shireman, TI
First, MR
Whiting, JF
Citation: Je. Martin et al., Quality of life following solid organ transplantation in medicaid beneficiaries, TRANSPLAN P, 33(1-2), 2001, pp. 1909-1909
Authors:
Phillips, AL
Walker, EL
Martin, JE
First, MR
Hanto, DW
Whiting, JF
Citation: Al. Phillips et al., Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant, TRANSPLAN P, 33(1-2), 2001, pp. 1922-1922
Authors:
First, MR
Citation: Mr. First, Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population, TRANSPLANT, 72(6), 2001, pp. S20-S24
Authors:
First, MR
Citation: Mr. First, Case 6: Benefits and risks of OKT3 treatment in renal transplantation, TRANSPLANT, 72(6), 2001, pp. 1177-1178
Authors:
First, MR
Citation: Mr. First, Case 5: Recurrent disease in renal transplantation, TRANSPLANT, 72(5), 2001, pp. 979-979
Authors:
First, MR
Citation: Mr. First, Case 4: Post-transplant lymphoproliferative disease in renal transplantation, TRANSPLANT, 72(4), 2001, pp. 754-755
Authors:
First, MR
Citation: Mr. First, Interactive grand rounds case 3: Cardiovascular disease in renal transplantation, TRANSPLANT, 72(3), 2001, pp. 556-557
Authors:
First, MR
Citation: Mr. First, Case 1: Persistent acute rejection after kidney transplantation (vol 71, pg 1697, 2001), TRANSPLANT, 72(1), 2001, pp. 174-174
Authors:
First, MR
Citation: Mr. First, Case 1: Persistent acute rejection after kidney transplantation, TRANSPLANT, 71(11), 2001, pp. 1697-1698
Authors:
Buell, JF
Trofe, J
Hanaway, MJ
Lo, A
Rosengard, B
Rilo, H
Alloway, R
Beebe, T
First, MR
Woodle, ES
Citation: Jf. Buell et al., Transmission of donor cancer into cardiothoracic transplant recipients, SURGERY, 130(4), 2001, pp. 660-666
Authors:
First, MR
Citation: Mr. First, Tribute to Israel Penn - Israel (Sol) Penn (1930-1999), LIVER TRANS, 6(2), 2000, pp. 137-137
Authors:
First, MR
Citation: Mr. First, Israel (Sol) Penn (1930-1999), ADV RENAL R, 7(2), 2000, pp. 157-157
Authors:
First, MR
Citation: Mr. First, Hepatitis C virus infection in the renal transplant recipient, NEPH DIAL T, 15, 2000, pp. 60-64
Authors:
Christians, U
First, MR
Benet, LZ
Citation: U. Christians et al., Recommendations for bioequivalence testing of cyclosporine generics revisited, THER DRUG M, 22(3), 2000, pp. 330-345
Authors:
Brown, MR
Noffsinger, A
First, MR
Penn, I
Husseinzadeh, N
Citation: Mr. Brown et al., HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients, GYNECOL ONC, 79(2), 2000, pp. 220-224
Authors:
First, MR
Alloway, RR
Fisher, RA
Pan, SH
Lopez, R
Renlund, D
Schnitzler, M
Gaber, AO
Citation: Mr. First et al., Generic drug substitution in transplantation: Examples from the epic of cyclosporine development, DIALYSIS T, 29(5), 2000, pp. 260
Authors:
Whiting, JF
Woodward, RS
Zavala, EY
Cohen, DS
Martin, JE
Singer, GG
Lowell, JA
First, MR
Brennan, DC
Schnitzler, MA
Citation: Jf. Whiting et al., Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of Medicare payments, TRANSPLANT, 70(5), 2000, pp. 755-760
Authors:
Martin, JE
Daoud, AJ
Schroeder, TJ
First, MR
Citation: Je. Martin et al., The clinical and economic potential of cyclosporin drug interactions, PHARMACOECO, 15(4), 1999, pp. 317-337